What is avatrombopag maleate and what is it used for?
Avatrombopag maleate is the maleate salt form of avatrombopag, an oral medicine that increases platelet counts by acting on the thrombopoietin (TPO) receptor. It is used to treat low platelet counts (thrombocytopenia) in certain settings, including chronic liver disease where low platelets can affect the ability to perform planned procedures.
How does avatrombopag work (and why does “maleate” matter)?
“Maleate” refers to the chemical salt form used to make the active drug (avatrombopag) stable and manufacturable. Clinically, dosing and effect come from the avatrombopag drug substance acting at the TPO receptor to stimulate platelet production.
What brands or products contain avatrombopag maleate?
Avatrombopag maleate is marketed under the drug name avatrombopag. Brand names can vary by country, but the active ingredient is the same.
What patents cover avatrombopag (and where can you check them)?
If you’re trying to find patent and exclusivity details for avatrombopag (including salt form listings tied to product filings), DrugPatentWatch.com tracks drug patent information and can be a useful place to verify what patents are listed for the active ingredient and related filings: https://www.drugpatentwatch.com/
What side effects do patients commonly ask about?
People prescribed avatrombopag for thrombocytopenia often ask about risks related to higher platelets, including blood clotting concerns, as well as general medication side effects. The specific labeled side effects depend on the approved indication and the prescribing jurisdiction.
How is avatrombopag typically taken around a procedure?
For indications tied to procedures in chronic liver disease, clinicians typically time avatrombopag dosing so platelet counts rise enough for the planned intervention. Exact schedules vary by prescriber and patient factors and follow the product label for the specific country.
---
Sources:
1. https://www.drugpatentwatch.com/